Search research articles
Contact Us
Filters
Showing results (71-80 of 115) with videos related to
Page
of 12
Sort By:
Human Pathology
|
September 26, 2006
Comprehensive expression analysis of L-dopa decarboxylase and established neuroendocrine markers in neoadjuvant hormone-treated versus varying Gleason grade prostate tumors
Latif A Wafa, Jodie Palmer, Ladan Fazli, et al.
Scientific Data
|
December 1, 2025
Bulk RNA sequencing dataset of Claudin-low breast cancer cell lines with Neuropilin-1 knockdown
Layla-Rose Lynam, Anja Rockstroh, Melanie Lehman, et al.
Current Oncology (Toronto, Ont.)
|
November 24, 2023
Introduction of Androgen Receptor Targeting shRNA Inhibits Tumor Growth in Patient-Derived Prostate Cancer Xenografts
Patrick B Thomas, Saeid Alinezhad, Andre Joshi, et al.
Journal of Natural Products
|
March 25, 2015
Design and Synthesis of a Screening Library Using the Natural Product Scaffold 3-Chloro-4-hydroxyphenylacetic Acid
Rohitesh Kumar, Martin C Sadowski, Claire Levrier, et al.
Oncogene
|
August 29, 2003
The intracellular E-cadherin germline mutation V832 M lacks the ability to mediate cell-cell adhesion and to suppress invasion
Gianpaolo Suriano, David Mulholland, Olivier de Wever, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 29, 2014
Isolation, structure determination and cytotoxicity studies of tryptophan alkaloids from an Australian marine sponge Hyrtios sp
Shahan Khokhar, Yunjiang Feng, Marc R Campitelli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 2, 2009
In vivo knockdown of the androgen receptor results in growth inhibition and regression of well-established, castration-resistant prostate tumors
Robert Snoek, Helen Cheng, Katia Margiotti, et al.
Plos One
|
September 8, 2012
Phenotypic characterization of prostate cancer LNCaP cells cultured within a bioengineered microenvironment
Shirly Sieh, Anna V Taubenberger, Simone C Rizzi, et al.
The Prostate
|
September 26, 2006
Relaxin becomes upregulated during prostate cancer progression to androgen independence and is negatively regulated by androgens
Vanessa C Thompson, Tanis G W Morris, Dawn R Cochrane, et al.
Oncotarget
|
September 9, 2017
Modulation of paracrine signaling by CD9 positive small extracellular vesicles mediates cellular growth of androgen deprived prostate cancer
Carolina Soekmadji, James D Riches, Pamela J Russell, et al.
Page
of 12
Search research articles
Search
Showing results (71-80 of 115) with videos related to
Sort By:
Page
of 12
Human Pathology
|
September 26, 2006
Comprehensive expression analysis of L-dopa decarboxylase and established neuroendocrine markers in neoadjuvant hormone-treated versus varying Gleason grade prostate tumors
Latif A Wafa, Jodie Palmer, Ladan Fazli, et al.
Scientific Data
|
December 1, 2025
Bulk RNA sequencing dataset of Claudin-low breast cancer cell lines with Neuropilin-1 knockdown
Layla-Rose Lynam, Anja Rockstroh, Melanie Lehman, et al.
Current Oncology (Toronto, Ont.)
|
November 24, 2023
Introduction of Androgen Receptor Targeting shRNA Inhibits Tumor Growth in Patient-Derived Prostate Cancer Xenografts
Patrick B Thomas, Saeid Alinezhad, Andre Joshi, et al.
Journal of Natural Products
|
March 25, 2015
Design and Synthesis of a Screening Library Using the Natural Product Scaffold 3-Chloro-4-hydroxyphenylacetic Acid
Rohitesh Kumar, Martin C Sadowski, Claire Levrier, et al.
Oncogene
|
August 29, 2003
The intracellular E-cadherin germline mutation V832 M lacks the ability to mediate cell-cell adhesion and to suppress invasion
Gianpaolo Suriano, David Mulholland, Olivier de Wever, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 29, 2014
Isolation, structure determination and cytotoxicity studies of tryptophan alkaloids from an Australian marine sponge Hyrtios sp
Shahan Khokhar, Yunjiang Feng, Marc R Campitelli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 2, 2009
In vivo knockdown of the androgen receptor results in growth inhibition and regression of well-established, castration-resistant prostate tumors
Robert Snoek, Helen Cheng, Katia Margiotti, et al.
Plos One
|
September 8, 2012
Phenotypic characterization of prostate cancer LNCaP cells cultured within a bioengineered microenvironment
Shirly Sieh, Anna V Taubenberger, Simone C Rizzi, et al.
The Prostate
|
September 26, 2006
Relaxin becomes upregulated during prostate cancer progression to androgen independence and is negatively regulated by androgens
Vanessa C Thompson, Tanis G W Morris, Dawn R Cochrane, et al.
Oncotarget
|
September 9, 2017
Modulation of paracrine signaling by CD9 positive small extracellular vesicles mediates cellular growth of androgen deprived prostate cancer
Carolina Soekmadji, James D Riches, Pamela J Russell, et al.
Page
of 12